Insider trades
Cormorant Private Healthcare Fund III, 10% Owner of MoonLake Immunotherapeutics MLTX, has filed 17 purchases and 20 sales on the open market. The latest trade was on 25/09/30.
Cormorant Private Healthcare Fund III
Former 10% Owner
- First filing
- 23/03/16
- Trades
- 40 trades
- Buys / sales
- 17 / 20
- 12-month net buying
- No record
- Last trade
- 25/09/30
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
MLTX | Open-market sale | 25/09/29–25/09/30 | 25/10/01 | 6,499,978 sh5 trades | $7.21avg. | $46,868,184.1 | −76.5% |
| Open-market sale | 25/05/15 | 25/05/19 | 1,813,439 sh | $1.85 | $3,354,862.15 | −100.0% | |
| Open-market sale | 25/05/12 | 25/05/14 | 24,300 sh | $1.99 | $48,357 | −1.3% | |
IMRX | Open-market sale | 24/04/01 | 24/04/03 | 400,000 sh8 trades | $2.90avg. | $1,160,182.5 | −12.1% |
IMRX | Open-market sale | 24/03/14–24/03/15 | 24/03/18 | 909,091 sh5 trades | $3.03avg. | $2,750,627.69 | −21.6% |
| Open-market buy | 23/10/23 | 23/10/25 | 1,307,311 sh | $6.99 | $9,138,103.89 | +13.2% | |
| Open-market buy | 23/10/05 | 23/10/10 | 58,839 sh | $59.90 | $3,524,456.1 | +0.7% | |
MLTX | Open-market buy | 23/10/02–23/10/04 | 23/10/04 | 293,212 sh3 trades | $57.30avg. | $16,800,123.3 | +3.6% |
| Open-market buy | 23/09/15–23/09/18 | 23/09/19 | 2,152,738 sh2 trades | $9.12avg. | $19,625,013.17 | +3.2% | |
| Open-market buy | 23/04/18–23/04/20 | 23/04/20 | 5,215,189 sh3 trades | $11.30avg. | $58,953,540.17 | +8.4% | |
| Open-market buy | 23/04/13–23/04/17 | 23/04/17 | 2,597,896 sh3 trades | $9.75avg. | $25,319,103.67 | +4.4% | |
Biomea FusionBMEA | Open-market buy | 23/03/30 | 23/04/03 | 400,000 sh | $30.00 | $12,000,000 | +12.6% |
| Open-market buy | 23/03/14–23/03/16 | 23/03/16 | 1,000,000 sh3 trades | $10.21avg. | $10,212,500 | +1.9% |
